de Graaf R, ten Have M, Beekman A. Economic costs of minor depression: a population-based study.
Introduction
Minor depression is a highly prevalent condition (1, 2), with a considerable impact on the quality of life of patients (3, 4) , and resulting in an increased utilization of medical services (5) . Minor depression is also associated with an increased mortality rate (6, 7) and carries a high risk of developing major depressive disorder on both the short (2) and the long term (8, 9) .
Despite these indications of clinical relevance, it is less clear whether minor depression is associated with increased economic costs. Although major depressive disorder is associated with considerable economic costs (10, 11) , as are other mental disorders (12) (13) (14) , the costs of minor depression remain unclear.
The few studies that have examined the economic burden of minor depression have reported increased service utilization and high medical costs in adults (5, (15) (16) (17) and among elderly (18) (19) (20) . However, most of these studies focused exclusively on direct medical costs, thereby ignoring patientsÕ out-of-pocket and time costs, and ignoring the often very substantial costs of production losses. Furthermore, several of these studies do not define minor depression according to diagnostic criteria but are based on self-reported symptoms. Most studies have focused on patients with minor depression who sought help for their problems, thereby ignoring those subjects who do not seek treatment. Finally, none of the studies has used a random sample of community residents with minor depression.
Aims of the study
To examine in a large, representative sample of the Dutch population whether minor depression is associated with significantly increased medical and non-medical costs. Furthermore, it was hypothesized that the costs of minor depression would be substantially smaller than those of major depression and dysthymia, which are generally considered to be more disabling. The study also examined whether there is a dose-response relationship between the number of depressive symptoms and economic costs and whether specific symptoms are associated with excess costs.
Material and methods

Subjects and procedure
This cost-of-illness study was conducted using the data of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) which has been described in detail elsewhere (21) , and is part of a series of studies on the costs of mental disorders. In brief, a random, stratified, multistage sample was obtained in three steps at baseline (t 0 ). First, municipalities were stratified by urbanization, and 90 municipalities were drawn randomly and proportionately from these strata. Second, within each municipality, households were randomly drawn from the postal register. Finally, within each household the person with the most recent birthday was selected on condition that he or she was aged between 18 and 65 years and sufficiently fluent in Dutch to be interviewed. Eligible persons who were not immediately available were contacted later in the year. The response rate was 69.7% resulting in a sample of 7076 people at t 0 . The baseline sample followed the same multivariate distribution over age, sex, civil status and urbanity as the general Dutch population; however, males in the age group 18-24 years were slightly underrepresented. All data were collected in structured face-to-face interviews.
At first follow-up (t 1 ), which occurred 1 year (M ¼ 379 days, SD ¼ 35) after baseline measurement, 5618 persons (79.4%) continued their participation. The present study is based on the t 1 sample because minor depression and medical consumption were measured at t 1 (and not, or not sufficiently, at t 0 ). Because we wanted to control for common mental disorders, we excluded from the analyses 114 subjects with DSM-III-R mental disorders with a 1-year prevalence below 1% (as measured with the Composite International Diagnostic Interview (CIDI), see below: bipolar disorder, obsessive-compulsive disorder, eating disorders and schizophrenia). This resulted in an effective sample size of n ¼ 5504.
Of this sample, 49% were women; the mean age was 40 (range 18-65 years); 69% was living with a partner; 5% had elementary education, 35% lower vocational, 30% secondary and 30% had higher vocational and academic education; 94% was born in the Netherlands; and 70% was employed.
We evaluated the effect of attrition from t 0 to t 1 and found no evidence that it was related to having a mental disorder at t 0 but, again, the younger males were more likely to be lost to follow-up (22) . Corrective weights were used to improve generalizability (see Analysis).
Measures DSM-III-R axis-I disorders were assessed in both waves with CIDI (23), Dutch 1.1 version (24) . The CIDI is a fully computerized psychiatric interview and can be used by trained interviewers who are not clinicians. It has an acceptable inter-rater and test-retest reliability for the disorders under study (25) .
In this study, the following disorders were examined: depressive disorder, dysthymia, anxiety disorder (presence of panic disorder with and without agoraphobia, generalized anxiety disorder, simple phobia, social phobia and/or agoraphobia without a history of panic) and alcohol-related disorder (alcohol misuse and/or alcohol dependence).
Minor depression. Because the CIDI does not provide an algorithm for the diagnosis of minor depression, we used a definition which best approached the DSM-IV definition. We defined minor depression as the subject reporting one of the core symptoms of depression between t 0 and t 1 during at least 2 weeks, plus at least one other symptom, but the total number of symptoms not exceeding four.
Major depression was defined according to the DSM-III-R classification and measured with the CIDI.
Chronic medical condition was assessed at t 0 with a questionnaire listing 31 common illnesses from the Health Survey of Statistics Netherlands, among them, diabetes mellitus, chronic obstructive lung disease, cardiac disease, arthritis of knee or hip and cancer (26) .
Sociodemographic characteristics were assessed in structured face-to-face interviews. The following variables were used: female gender, age (in years), education, living with a partner, born in the Netherlands or elsewhere, employment status. Because the time frame of this study is restricted to this single year, we did not correct for inflation and did not discount costs. Conceptually, the following types of costs can be distinguished.
Direct medical costs are the costs of health service resource use. All direct medical costs refer to costs made in the mental healthcare sector in the Netherlands. There were only three exceptions: we also included GP costs, costs of social work and physiotherapy. This was done because people with mental problems often make use of their services. Information on the subjectsÕ use of health services was obtained with a prototype version of the Trimbos and Institute of Medical Technology Assessment Cost questionnaire for Psychiatry (TIC-P) (27) . This questionnaire registers the number of general practitioner visits, sessions with psychiatrists, hospital days, etc. In a next step, medical resource use was calculated by multiplying the number of health service units (consultations, hospital days, etc.) by their integral cost price (28) .
To these costs we added the costs of pharmacological interventions as the cost price per standard daily dose (obtained from the Pharmaceutical Compass at http://www.fk.cvz.nl), plus 6% VAT, multiplied by the number of prescription days, plus the pharmacist's dispensing costs of US$ 7.91 per prescription.
Direct non-medical costs arise when patients travel to health service providers and pay for parking. In the Netherlands, the average travel distance between a random address and a general practitioner's practice is 1.8 km. Travel distances to other health services are also known (28) . This information was combined with the information about actual use of health services. Travel distances were valued at US$ 0.17 per km and 1 h parking time was valued at US$ 2.70. To this we added the costs of the patientsÕ time spent in travel, waiting and in treatment at US$ 9.00 per hour (see Appendix 1) .
Indirect non-medical costs arise when production losses occur due to illness. Subjects were asked about the number of days spent in bed due to illness. These days in bed are split according to workdays (resulting in production losses due to loss of work days) and days spent in bed while not having to work (resulting in production losses in the domestic sphere). To value a lost day in a paid job we used the costs which represent the age and gender-specific monetary counter-value of production losses that occur during absence from work (29) .
For persons too ill to perform domestic tasks, these costs were valued at the black market price of domestic help at US$ 9.00 per hour. The black market price is used for these costs because they are assumed to reflect the true costs.
The cost calculations were conducted in accordance with the latest Dutch guideline for health economic evaluations (28) , which closely resembles other international guidelines (30) (31) (32) .
Analysis
Our analytical strategy consisted of establishing a baseline of the costs across different diagnostic categories, after which we computed the additional or excess costs over and above that base rate. The base rate consists of the costs which are generated annually by every person, on average.
Economic costs of minor depression
First, we conducted a series of multiple regression analyses. In the first analysis, the overall excess per capita costs (the costs above the base rate) were used as dependent variable, while the presence of minor depression, major depression, dysthymia, any anxiety, any alcohol-related disorder and somatic disorders were used as predictors. This allowed us to examine the costs of minor depression, while controlling for other common mental disorders. In the second regression analysis, we used direct medical excess costs as dependent variable and the same variables as predictors. In the third and fourth regression analyses, the direct non-medical and the indirect non-medical costs were used as the dependent variables.
To account for initial non-response and dropout, corrective weights were used. After weighting, the sample followed exactly the same multivariate distribution over age, sex, civil status and urbanization as the population according to Statistics Netherlands (downloadable from http:// www.cbs.nl).
To account for the possible non-normality of the cost data, sample errors, 95% confidence intervals (CIs) and P-values were based on 1000 bootstrap replications, while at each bootstrap step robust sample errors were obtained using the first-order Tailor-series linearization method. The latter was done to obtain correct 95% CIs and P-values under weighting.
The bootstrap method is often used for getting 95% CIs in economic studies, especially when it is expected that standard statistical (asymptotic) theory may not hold -as might have been the case for the non-normally distributed cost data. For our data we found that the 95% bootstrap intervals were nearly identical with the 95% CIs that were obtained with help of the robust standard errors (based on the Hubert-White sandwich method). So, there is no appreciable difference. Nevertheless, we lend preference to the bootstrap intervals, because they are more robust.
Next, we recalculated the per capita costs into the costs per 1 million inhabitants (on the basis of the societal costs per capita and the prevalence rates for each disorder). For these costs per 1 million inhabitants, we used the prevalence rates of mental disorders as reported earlier (2, 21) .
Then we examined whether the costs of minor depression were related to the number of depressive symptoms. We devised three categories of minor depression (with two, three or four symptoms). We then regressed the total societal per capita costs on these three types of minor depression, major depression, dysthymia, any anxiety disorder and any alcohol-related disorder, while adjusting for somatic illnesses. Again, we recalculated the per capita costs of each of these three types of minor depression into the costs per 1 million inhabitants.
To examine whether an increase in number of symptoms in minor depression was related to an increase in costs, we conducted a new regression analysis with the economic costs as dependent variable and the number of symptoms as predictor, while controlling for other common mental disorders and for somatic disorders (P for linear trend).
Finally, we examined whether the excess costs of minor depression were related to specific symptoms. We made a new variable indicating whether the subject had minor depression with lack of appetite (one of the symptoms of depressive disorders) or minor depression without lack of appetite. Then we entered both variables as predictors in a multivariate regression analysis (while partialling out the excess costs of major depression, dysthymia, any anxiety and any alcohol-related disorder, and adjusting for the presence of somatic disorders). We repeated this procedure for every symptom of depression. Because we found no significant effects and because the standard errors were large (as generally occurs in costof-illness studies in psychiatric disorders), we decided to calculate both the 95% CIs and 90% CIs (all based on 1000 bootstrap replications).
All analyses were conducted with Stata version 7.0/SE (Stata Corp., College Station, TX, USA).
Results
Per capita costs and costs at the population level Table 1 shows that the annual excess per capita costs of having minor depression is, on average, US$ 2141 (SE ¼ 708; 95% CI ¼ 753-3529), while the excess costs of major depression are US$ 3313 (SE ¼ 1061; 95% CI ¼ 1234-5390).
As indicated earlier, these costs should be interpreted as the excess costs of the disorder, because every person generates, on average, a Ôbase rateÕ of US$ 1023 annually. The actual costs when someone experiences an episode of minor depression are in a given year US$ 2141 + US$ 1023 ¼ US$ 3164. The annual direct medical and direct non-medical excess costs are very small and nonsignificant for minor depression, indicating that subjects with minor depression receive hardly any excess professional help compared to subjects without mental or other disorders. The indirect non-medical costs are significantly different from the base rate and are relatively high (US$ 2101).
These latter costs approach the costs of major depression (US$ 2535).
We used the per capita costs to calculate the costs per 1 million inhabitants aged 18-65 years. This includes all cost categories (health service uptake, out-of-pocket costs, production losses; and is equivalent to the per capita excess costs · prevalence · 1 000 000). Table 2 shows that the costs of minor depression are 160 million dollars per year, which is somewhat less than the 192 million dollars per year for major depression. Thus, the economic costs associated with both disorders are considerable.
Costs associated with the number of symptoms
We examined the possibility that an increasing number of symptoms is associated with higher per capita costs by calculating the per capita costs associated with minor depression with two symptoms, three and with four symptoms. The results are presented in Fig. 1 . The per capita costs increased significantly with the increasing number of symptoms (two symptoms: US$ 987, three: US$ 2866 and four: US$ 3474; P for linear trend <0.001).
We also calculated the number of subjects with minor depression with two, three and four symptoms, and the total annual costs per 1 million inhabitants. Although the number of subjects with these three types of minor depression decreases somewhat with the increase in the number of symptoms (prevalence of 0.025 for two symptoms, 0.026 for three and 0.023 for four symptoms; overall prevalence 0.075), the total annual costs per 1 million inhabitants increases strongly with the increase in the number of symptoms.
Costs associated with specific symptoms
We found only few indications that specific symptoms of minor depression were associated with increased per capita costs. None of the analyses reached a significance level of 0.05. Because the standard errors were large, we also calculated the 90% CIs (Table 3) . We found a trend (p < 0.1) indicating that the costs associated with minor depression in which lack of appetite was present were lower than the costs associated with minor depression without lack of appetite. Furthermore, (Robust) sample errors and 95% CIs are based on 1000 bootstraps. àThe sum of the direct medical, direct non-medical and indirect non-medical costs is not exactly the same as the total costs, because each type of cost was estimated separately and may vary slightly. there was a trend indicating that feelings of worthlessness and guilt in minor depression were associated with higher per capita costs.
Discussion
In the present study the economic costs associated with minor depression were found to be considerable, and approaching the costs of major depression. Per million inhabitants, the excess costs were about 160 million dollars, compared to about 190 million dollars for major depression. Minor depression was hardly associated with increased direct medical and direct non-medical costs, and virtually all excess costs were those associated with production losses due to illness (i.e. indirect nonmedical costs). This indicates that subjects with minor depression do not receive more professional help than the average person, which is in contrast to other studies reporting that minor depression is associated with more use of mental health services (2, 5) . However, most research in this area has focused on subjects who actually receive professional help and have not used data from the general population.
However, in an earlier analysis of the same data, we found that minor depression was associated with increased use of services (2) . The reason for this discrepancy is that in the present study we controlled for comorbid mental disorders, which was not done in our earlier study.
In the present study the per capita excess costs of major depression were substantially higher than those of minor depression, but because the prevalence of minor depression was higher, the total costs per million inhabitants were similar in both disorders. This is an important finding from a public health perspective: At the individual level minor depression costs less, but at the population level the costs are considerable and approach those of major depression. This suggests that large-scale treatment of minor depression will probably result in increased medical costs, but may be costeffective from a societal perspective.
There was evidence to support our hypothesis that a larger number of symptoms of depression are associated with higher excess per capita costs in minor depression. Because most excess costs are non-medical costs, this suggests that a larger number of symptoms is associated with more role limitations and more production losses.
Apart from the number of symptoms, the excess per capita costs could also be associated with specific symptoms. On examination we found some (contra-intuitive) indications that lack of appetite may be associated with lower costs. In addition, feelings of worthlessness may be associated with higher costs. These latter results indicate that it is not so much the type of symptom, but the number of symptoms which is associated with excess costs.
This study has several strengths and limitations. Strengths include the relatively large, representative community sample (n ¼ 5504), the inclusion of direct medical and non-medical costs, as well as the indirect non-medical costs, and the use of wellvalidated diagnostic instruments to assess the presence of mental disorders. There are, however, also some limitations. First, we used data from the second measurement point of the NEMESIS study; at this measurement point some attrition had taken place which may have distorted the results. However, corrective weights were used to control for selective drop-out.
Second, we used a definition of minor depression which approached the DSM-IV definition. However, whereas the DSM-IV definition stipulates that the symptoms should co-occur during 2 weeks, our definition defined minor depression as having had the symptoms during 1 year. Thus in some cases, the symptoms may have occurred at Costs are the societal costs, including direct medical, direct non-medical and indirect non-medical costs. à(Robust) sample errors and 90% confidence intervals are based on 1000 bootstraps. §The sum of the direct medical, direct non-medical and indirect non-medical costs is not exactly the same as the total costs, because each type of cost was estimated separately and may vary slightly. -* and ** indicate that the costs differ significantly from the mean costs; *p < 0.05; **p < 0.01. different times during the past years. This may have lead to misclassification in some cases: some participants may have been diagnosed with minor depression while they did not experience all the symptoms simultaneously. This type of misclassification is especially important when the diagnosis spans longer periods of time (for instance when studying the life time occurrence of disorders). In a study of the 1-year occurrence of disorders it is much less likely to have an effect. However, some misclassification may have occurred. The effect would be that participants with less than the required symptoms were classified as minor depression, which would probably lead to an underestimation of the true costs of minor depression.
Third, although our number of subjects was large, it was relatively small for economic studies (33) . This resulted in large standard errors and confidence intervals.
The costs reported in this paper should be interpreted as conservative estimates for the following reasons. First, the medical costs that were considered in this study were limited to those related to mental health services and psychopharmaca, whereas it is well known that mental disorders also generate medical costs outside the sector of mental health services (34) . Second, the cost calculations were based on self-reported medical consumption, which is known to result in an underestimate of the medical consumption and the corresponding costs (35) . Third, people who are ill but still go to their job may work less efficiently, resulting in production losses; such production losses are not included in this study, but can be substantial. (36, 37) .
This study has shown that minor depression is not only an important health problem but also involves considerable economic costs, approaching those of major depression. From a public health point of view, it is important to continue the attempts to develop treatments for minor depression and to test their effects (38, 39) . 
